Ben Hargreaves examines how AI cancer diagnosis is currently being implemented, and how it could evolve in the years ahead, including the potential for the exploration of digital biomarkers
Following the European Society of Gynaecological Oncology (ESGO) 2022 congress, pharmaphorum spoke with experts from among the Ovarian Cancer Commitment (OCC) founding partners – ESGO, the
